Successful Industrial Cannabis Cultivation in Santa Martha Chichihualtepec

Regulations by 2FIRSTS.ai
Jan.19.2024
Successful Industrial Cannabis Cultivation in Santa Martha Chichihualtepec
According to Mexican media pagina3, Santa Martha Chichihualtepec community successfully conducted its first industrial-scale marijuana cultivation and harvest.

According to a report by Mexican media outlet pagina3 on January 18, the community of Santa Martha Chichihualtepec in the state of Oaxaca has successfully conducted its first experimental cultivation and harvest of marijuana for industrial purposes, marking their first achievement in obtaining a marijuana yield with industrial manufacturing potential.

 

The state of Santa Marta Chiquihuáltepec in Oaxaca, Mexico has successfully harvested hemp for the first time, which can be used in the production of textiles, thread, ropes, soap, and other industrial products. According to Horacio Sosa, a representative from the Morena party who is involved in the project, Oaxaca is the first state in Mexico to promote such initiatives, focusing on biocultural architecture and sustainable product manufacturing goals.

 

Sosa Villavicencio emphasized that the project has obtained health permits from the Federal Commission for the Protection against Sanitary Risks (Cofepris). The project was initiated by local farmer families and aims to cater to the emerging needs of the industrial market. He stated that Mexico has enormous potential in developing the cannabis industry, with the key lying in accurately defining medical, recreational, and industrial uses of marijuana within the legal framework.

 

Sousa also stated that, from the perspective of the legislation body in Osaca state, they will strengthen efforts to promote local producers benefiting directly from this new market opportunity. He emphasized the crucial role of developing regulations to support local farming families, ensuring they can fully exploit this global development opportunity.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files
FDA and NIH Release New Wave 8 Restricted-Use PATH Study Data Files
FDA’s Center for Tobacco Products and NIH’s National Institute on Drug Abuse announced that new Wave 8 restricted-use data files from the PATH Study are now available. The files contain data collected between January 2024 and December 2024, including questionnaire data, location characteristics data, and state identifier data.
Apr.17 by 2FIRSTS.ai
Tennessee House Advances Bill to Direct Vape Tax Revenue to Youth Nicotine Prevention
Tennessee House Advances Bill to Direct Vape Tax Revenue to Youth Nicotine Prevention
The Tennessee House of Representatives advanced legislation this week aimed at curbing underage use of vapor products. House Bill 2360 would allocate 30% of tax revenue from vapor products to counties to support youth nicotine prevention programs across the state.
Mar.23 by 2FIRSTS.ai
WSJ: White House Pushes for More Flavored Vape Approvals as FDA Commissioner Makary Blocks Move
WSJ: White House Pushes for More Flavored Vape Approvals as FDA Commissioner Makary Blocks Move
According to The Wall Street Journal, the White House is pushing to allow more flavored vape products onto the market for the first time in years, but FDA Commissioner Marty Makary opposes the move and has blocked the plan. The report said a memo from Makary’s office prevented authorization of several flavors from vape maker Glas, even after FDA scientific reviewers had supported them.
Apr.20 by 2FIRSTS.ai
FDA Filing Shows RIF Notices for 229 CTP Employees Were Largely Rescinded
FDA Filing Shows RIF Notices for 229 CTP Employees Were Largely Rescinded
A court declaration signed by FDA official Melanie M. Keller on March 24, 2026 detailed the status of previously issued reduction-in-force notices affecting employees at the Center for Tobacco Products (CTP).
Apr.01 by 2FIRSTS.ai
Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Reports Q1 2026 Net Revenues of $5.43 Billion and 7.3% Growth in Adjusted Diluted EPS
Altria Group reported its first-quarter 2026 results on April 30. Net revenues were $5.43 billion, up 3.2% year on year, while revenues net of excise taxes were $4.76 billion, up 5.3%. Reported diluted EPS was $1.30, up more than 100%, and adjusted diluted EPS was $1.32, up 7.3%.
May.06 by 2FIRSTS.ai
Philip Morris Korea Names Lee Hong-seok as New CEO Effective May 1
Philip Morris Korea Names Lee Hong-seok as New CEO Effective May 1
Philip Morris Korea said on April 29 that it has appointed Lee Hong-seok, head of its smoke-free products division, as its new chief executive officer, with his term beginning on May 1. Yoon Hee-kyung, who took office in 2023, will step down after about three years in the role.
Apr.30 by 2FIRSTS.ai